Results 101 to 110 of about 584,610 (216)
Zi-Long Zhang,1,2,* Jun-Song Yang,1,* Ding-Jun Hao,1 Tuan-Jiang Liu,1 Qi-Ming Jing2,* 1Department of Spine Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China; 2Graduate School of Xi’an
Zhang ZL +4 more
core
The broadening spectrum of osteoporotic vertebral fracture [PDF]
Osteoporotic bone is structurally insufficient and predisposed to low-energy fracture [1]. Fractures are deemed osteoporotic when they result from generalized skeletal demineralization and low-energy trauma rather than from focal pathologic destruction of bone or high-energy trauma.
openaire +2 more sources
Outcome of patients undergoing vertebroplasty for painful osteoporotic vertebral fractures
Outcome of patients undergoing vertebroplasty for painful osteoporotic vertebral ...
D Connell (7794695) +4 more
core
A predictive mechanical model for evaluating vertebral fracture probability in lumbar spine under different osteoporotic drug therapies [PDF]
Osteoporotic vertebral fractures represent a major cause of disability, loss of quality of life and even mortality among the elderly population. Decisions on drug therapy are based on the assessment of risk factors for fracture from bone mineral density (
Herrera,A. +8 more
core +1 more source
The overall purpose of this study was to explore the efficacy of denosumab in the treatment of osteoporotic vertebral fractures and to compare the efficacy of denosumab in osteoporotic vertebral compression fracture (OVCF) patients with or without a ...
Yixuan Jiang +8 more
doaj +1 more source
Purpose. To evaluate the cost-effectiveness of denosumab versus other osteoporotic treatments in older men with osteoporosis from a US payer perspective. Methods.
Stuart Silverman +4 more
doaj +1 more source
Vertebroplasty was not effective for painful osteoporotic vertebral fractures
Vertebroplasty was not effective for painful osteoporotic vertebral ...
AP Mitchell (7767482) +8 more
core
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
Bisphosphonates are the leading drugs for the treatment of osteoporosis. In randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ...
Graham Russell +4 more
core +1 more source
A review of anatomical and mechanical factors affecting vertebral body integrity
Background: The aetiology of osteoporotic vertebral fracture is multifactorial and may be conceptualised using a systems framework. Previous studies have established several correlates of vertebral fracture including reduced vertebral cross-sectional ...
doaj
Ahmad Shuid Nazrun,1 Mohd Nizam Tzar,2 Sabarul Afian Mokhtar,3 Isa Naina Mohamed1 1Department of Pharmacology, 2Department of Medical Microbiology and Immunology, 3Department of Orthopedic, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur,
Nazrun AS +3 more
doaj

